missing translation for 'onlineSavingsMsg'
Learn More

Refametinib, MedChemExpress

Code produit. 16496128
Encompass_Preferred
Click to view available options
Quantité:
5 mg
10 mg
50 mg
100 mg
Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.

Code produit. 16496128

Marque: Medchem Express HY14691

Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!

Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.

MedChemExpress Refametinib (BAY 869766; RDEA119) is an orally available, potent, non-ATP-competitive, selective, allosteric MEK1/MEK2 inhibitor with IC50s of 19 nM and 47 nM, respectively.

Refametinib (BAY 869766

Specifications

Nom chimique ou matériau Refametinib
CAS 923032-37-5
Couleur Earth Yellow
Notes de qualité de la pureté Research
Formule moléculaire C19H20F3IN2O5S
Quantité 10 mg
Synonyme BAY 869766 RDEA119
Informations sur la solubilité DMSO : ≥ 31 mg/mL (54.16 mM)
SMILES O=S(C1(C[C@H](O)CO)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
Poids moléculaire (g/mol) 572.34
Poids de la formule 572.34
Pourcentage de pureté 98.97%
Qualité Research
Forme physique Solid
À utiliser avec (application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.